Published in Dig Dis Sci on July 16, 2009
Staphylococcal enterotoxins. Toxins (Basel) (2010) 1.93
Staphylococcal and streptococcal superantigen exotoxins. Clin Microbiol Rev (2013) 1.48
A systematic review for pursuing the presence of antibiotic associated enterocolitis caused by methicillin resistant Staphylococcus aureus. BMC Infect Dis (2014) 0.79
The staphylococcal enterotoxins and their relatives. Science (1990) 11.99
Clostridium difficile colitis. N Engl J Med (1994) 9.31
Exotoxins of Staphylococcus aureus. Clin Microbiol Rev (2000) 7.35
The gene for toxic shock toxin is carried by a family of mobile pathogenicity islands in Staphylococcus aureus. Mol Microbiol (1998) 5.21
Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol (2001) 4.48
Pseudomembranous colitis. J Clin Pathol (1977) 3.93
Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol (1990) 3.89
Superantigens and their potential role in human disease. Adv Immunol (1993) 3.88
The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J Exp Med (1990) 3.31
The structural basis of T cell activation by superantigens. Annu Rev Immunol (1999) 2.34
Sepsis with coagulase-negative staphylococci in critically ill newborns. Am J Dis Child (1983) 1.86
Quorum sensing in Staphylococcus infections. J Clin Invest (2003) 1.79
Staphylococcal enterocolitis following antibiotic therapy. Ann Surg (1963) 1.71
Toxic shock syndrome. A newly recognized complication of influenza and influenzalike illness. JAMA (1987) 1.69
Three-dimensional structure of the complex between a T cell receptor beta chain and the superantigen staphylococcal enterotoxin B. Immunity (1998) 1.68
The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc alpha RI binding and serum killing of bacteria. J Immunol (2005) 1.67
Staphylococcus aureus and Clostridium difficile cause distinct pseudomembranous intestinal diseases. Clin Infect Dis (2004) 1.58
Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospitalized adults. JAMA (2001) 1.53
Crystal structure of a superantigen bound to the high-affinity, zinc-dependent site on MHC class II. Immunity (2001) 1.42
Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus. J Clin Microbiol (2006) 1.31
Predominant Staphylococcus aureus isolated from antibiotic-associated diarrhea is clinically relevant and produces enterotoxin A and the bicomponent toxin LukE-lukD. J Clin Microbiol (1999) 1.26
Anergy and cytokine-mediated suppression as distinct superantigen-induced tolerance mechanisms in vivo. J Exp Med (1999) 1.24
Mucosal vaccination with recombinantly attenuated staphylococcal enterotoxin B and protection in a murine model. Infect Immun (2001) 1.23
Transcytosis of staphylococcal superantigen toxins. J Exp Med (1997) 1.20
Delta-like toxin produced by coagulase-negative staphylococci is associated with neonatal necrotizing enterocolitis. Infect Immun (1987) 1.20
Intra-epithelial lymphocytes. Evidence for regional specialization and extrathymic T cell maturation in the human gut epithelium. Int Immunol (1995) 1.19
Nosocomial antibiotic-associated diarrhea associated with enterotoxin-producing strains of methicillin-resistant Staphylococcus aureus. Am J Gastroenterol (2005) 1.17
Superantigen binding to a T cell receptor beta chain of known three-dimensional structure. J Exp Med (1995) 1.16
Clostridium difficile enteritis: an early postoperative complication in inflammatory bowel disease patients after colectomy. J Gastrointest Surg (2007) 1.15
Staphylococcus epidermidis bacteremia in neonates: further observations and the occurrence of focal infection. Pediatrics (1984) 1.13
The significance of the isolation of coagulase-positive staphylocci from stool. With special reference to the diagnosis of staphyloccocal enteritis. Am J Clin Pathol (1960) 1.12
Focal gastrointestinal perforations not associated with necrotizing enterocolitis in very low birth weight neonates. J Pediatr Surg (1993) 1.11
The effect of an enhanced infection-control policy on the incidence of Clostridium difficile infection and methicillin-resistant Staphyloccocus aureus colonization in acute elderly medical patients. Age Ageing (1998) 1.08
Clinical studies of enteritis caused by methicillin-resistant Staphylococcus aureus. Eur J Surg (2001) 1.08
Toxinogenicity of clinical isolates of coagulase-negative staphylococci towards various animal cells. Acta Pathol Microbiol Scand B (1981) 1.07
The role of Clostridium difficile and viruses as causes of nosocomial diarrhea in children. Infect Control Hosp Epidemiol (2002) 1.06
Pseudomembranous enterocolitis; the experimental induction of the disease with Staphylococcus aureus and its enterotoxin. AMA Arch Surg (1959) 1.05
Managing methicillin-resistant staphylococci: a paradigm for preventing nosocomial transmission of resistant organisms. Am J Infect Control (2006) 1.05
Activation of mucosal V beta 3+ T cells and tissue damage in human small intestine by the bacterial superantigen, Staphylococcus aureus enterotoxin B. Eur J Immunol (1993) 1.05
Changes in murine jejunal morphology evoked by the bacterial superantigen Staphylococcus aureus enterotoxin B are mediated by CD4+ T cells. Infect Immun (1998) 1.00
CD4+ T cells mediate superantigen-induced abnormalities in murine jejunal ion transport. Am J Physiol (1998) 0.98
Methicillin-resistant Staphylococcal enterocolitis. Am J Med (1998) 0.94
Staphylococcal enterocolitis revisited: cytotoxic properties of Staphylococcus aureus from a neonate with enterocolitis. Pediatr Infect Dis J (1988) 0.94
The role of coagulase-negative Staphylococcus in neonatal necrotizing enterocolitis. J Pediatr Surg (1988) 0.93
Methicillin-resistant Staphylococcus aureus (MRSA) enteritis associated with prophylactic cephalosporin administration and hypochlorhydria, after subtotal gastrectomy. Am J Gastroenterol (1991) 0.93
Molecular epidemiology of enteritis-causing methicillin-resistant Staphylococcus aureus. J Hosp Infect (2005) 0.93
Distinctive distribution of pathogens associated with peritonitis in neonates with focal intestinal perforation compared with necrotizing enterocolitis. Pediatrics (2005) 0.92
Neonatal staphylococcal enterocolitis: association with indwelling feeding catheters and S. aureus colonization. J Pediatr (1976) 0.91
Neonatal necrotizing enterocolitis associated with delta toxin-producing methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J (1990) 0.88
Methicillin-resistant Staphylococcus aureus as a cause of antibiotic-associated diarrhea. J Clin Gastroenterol (2004) 0.88
Effects of staphylococcal enterotoxin A on the rat gastrointestinal tract. Infect Immun (1984) 0.88
Staphylococcus epidermidis-associated enterocolitis. J Pediatr (1986) 0.87
Staphylococcal enterotoxin B induces potent cytotoxic activity by intraepithelial lymphocytes. Immunology (2000) 0.86
Prevalence of enterotoxin producing Staphylococcus aureus in stools of patients with nosocomial diarrhea. Infection (2007) 0.86
Nosocomial diarrhea. Crit Care Clin (1998) 0.84
Fatal staphylococcal enteritis developing during streptomycin therapy by mouth. Lancet (1948) 0.84
Necrotizing enterocolitis in a married couple due to a staphylococcal toxin. Eur J Gastroenterol Hepatol (2001) 0.83
Toxic shock-like syndrome associated with staphylococcal enterocolitis in an HIV-infected man. Clin Infect Dis (2007) 0.83
Postoperative methicillin-resistant Staphylococcus aureus enteritis following hysterectomy: a case report and review of the literature. Eur J Gastroenterol Hepatol (2005) 0.81
Enterocolitis caused by methicillin-resistant Staphylococcus aureus. Lancet (1993) 0.81
Multiple intestinal ulcerations and perforations secondary to methicillin-resistant Staphylococcus aureus enteritis in infants. J Pediatr Surg (1999) 0.80
Enterocolitis due to methicillin-resistant Staphylococcus aureus--report of two cases. Bull Tokyo Med Dent Univ (1992) 0.80
IL-15 is elevated in the patients of postoperative enterocolitis. Cytokine (1999) 0.80
Cholera-like diarrhea and shock associated with community-acquired methicillin-resistant Staphylococcus aureus (USA400 clone) pneumonia. Pediatr Infect Dis J (2007) 0.78
Toxic shock syndrome associated with Staphylococcus aureus enterocolitis. Pediatr Infect Dis J (1988) 0.78
Staphylococcal enterotoxin A modulates intracellular Ca2+ signal pathway in human intestinal epithelial cells. FEBS Lett (2005) 0.77
ANTIBIOTICS, staphylococcal enteritis and pseudomembranous enterocolitis. N Engl J Med (1953) 0.76
Successful treatment of methicillin-resistant Staphylococcus aureus (MRSA) enterocolitis in a neutropenic patient following cytotoxic chemotherapy. Am J Hematol (1993) 0.75
Colonic stenosis after severe methicillin-resistant Staphylococcus aureus enterocolitis in a newborn. Pediatr Infect Dis J (1999) 0.75
Low mortality in necrotizing enterocolitis associated with coagulase-negative Staphylococcus infection. Pediatr Surg Int (2008) 0.75
Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc Natl Acad Sci U S A (2002) 5.07
Glycerol monolaurate prevents mucosal SIV transmission. Nature (2009) 5.02
Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat. Am J Clin Nutr (2002) 3.33
Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin Infect Dis (2003) 2.90
Purpura fulminans due to Staphylococcus aureus. Clin Infect Dis (2005) 2.27
State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary. Circulation (2008) 2.17
Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel. J Acquir Immune Defic Syndr (2002) 1.98
Characterization of virulence factor regulation by SrrAB, a two-component system in Staphylococcus aureus. J Bacteriol (2004) 1.91
Nonalcoholic fatty liver disease in severely obese subjects. Am J Gastroenterol (2007) 1.90
Characterization and expression analysis of Staphylococcus aureus pathogenicity island 3. Implications for the evolution of staphylococcal pathogenicity islands. J Biol Chem (2002) 1.88
Body-size dependence of resting energy expenditure can be attributed to nonenergetic homogeneity of fat-free mass. Am J Physiol Endocrinol Metab (2002) 1.82
Quorum sensing in Staphylococcus infections. J Clin Invest (2003) 1.79
Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV. Am J Gastroenterol (2007) 1.77
Repression of the Staphylococcus aureus accessory gene regulator in serum and in vivo. J Bacteriol (2002) 1.73
Independent associations of insulin resistance with high whole-body intermuscular and low leg subcutaneous adipose tissue distribution in obese HIV-infected women. Am J Clin Nutr (2007) 1.63
The innate immune system is activated by stimulation of vaginal epithelial cells with Staphylococcus aureus and toxic shock syndrome toxin 1. Infect Immun (2005) 1.62
Intermuscular adipose tissue-free skeletal muscle mass: estimation by dual-energy X-ray absorptiometry in adults. J Appl Physiol (1985) (2004) 1.57
Extreme pyrexia and rapid death due to Staphylococcus aureus infection: analysis of 2 cases. Clin Infect Dis (2009) 1.55
Temperature regulates bacterial protein production: possible role in rosacea. J Am Acad Dermatol (2004) 1.55
Genome diversification in Staphylococcus aureus: Molecular evolution of a highly variable chromosomal region encoding the Staphylococcal exotoxin-like family of proteins. Infect Immun (2003) 1.53
Neutralization of staphylococcal enterotoxin B by soluble, high-affinity receptor antagonists. Nat Med (2007) 1.52
Staphylococcal and streptococcal superantigen exotoxins. Clin Microbiol Rev (2013) 1.48
Reduction in Staphylococcus aureus growth and exotoxin production and in vaginal interleukin 8 levels due to glycerol monolaurate in tampons. Clin Infect Dis (2009) 1.48
Staphylococcal toxic shock syndrome erythroderma is associated with superantigenicity and hypersensitivity. Clin Infect Dis (2009) 1.47
Beta toxin catalyzes formation of nucleoprotein matrix in staphylococcal biofilms. Proc Natl Acad Sci U S A (2010) 1.44
Staphylococcal toxic shock syndrome 2000-2006: epidemiology, clinical features, and molecular characteristics. PLoS One (2011) 1.43
Structure and biological activities of beta toxin from Staphylococcus aureus. J Bacteriol (2007) 1.43
Effect of recombinant human growth hormone on exercise capacity in patients with HIV-associated wasting on HAART. AIDS Read (2005) 1.40
Association of antiretroviral therapy with fibrinogen levels in HIV-infection. AIDS (2008) 1.38
A novel core genome-encoded superantigen contributes to lethality of community-associated MRSA necrotizing pneumonia. PLoS Pathog (2011) 1.37
Recombinant human growth hormone to treat HIV-associated adipose redistribution syndrome: 12 week induction and 24-week maintenance therapy. J Acquir Immune Defic Syndr (2007) 1.37
In vivo induction of virulence and antibiotic resistance transfer in Enterococcus faecalis mediated by the sex pheromone-sensing system of pCF10. Infect Immun (2002) 1.35
Body cell mass: model development and validation at the cellular level of body composition. Am J Physiol Endocrinol Metab (2003) 1.33
Glycerol monolaurate inhibits the effects of Gram-positive select agents on eukaryotic cells. Biochemistry (2006) 1.33
Structures of two streptococcal superantigens bound to TCR beta chains reveal diversity in the architecture of T cell signaling complexes. Structure (2002) 1.31
Gram-positive bacterial superantigen outside-in signaling causes toxic shock syndrome. FEBS J (2011) 1.29
Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women. Metabolism (2006) 1.29
Virulence regulation in Staphylococcus aureus: the need for in vivo analysis of virulence factor regulation. FEMS Immunol Med Microbiol (2004) 1.28
Cytolysins augment superantigen penetration of stratified mucosa. J Immunol (2009) 1.27
HIV infection and the gastrointestinal tract. AIDS (2005) 1.26
Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors. Circulation (2008) 1.24
Relationship of fat distribution with adipokines in human immunodeficiency virus infection. J Clin Endocrinol Metab (2007) 1.24
Characterization of a novel staphylococcal enterotoxin-like superantigen, a member of the group V subfamily of pyrogenic toxins. Biochemistry (2002) 1.23
Superantigens are critical for Staphylococcus aureus Infective endocarditis, sepsis, and acute kidney injury. MBio (2013) 1.19
Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy. Am J Physiol Endocrinol Metab (2003) 1.19
Staphylococcal superantigens cause lethal pulmonary disease in rabbits. J Infect Dis (2010) 1.18
An amino-terminal domain of Enterococcus faecalis aggregation substance is required for aggregation, bacterial internalization by epithelial cells and binding to lipoteichoic acid. Mol Microbiol (2004) 1.14
Insulin resistance, glucose intolerance and diabetes mellitus in HIV-infected patients. Antivir Ther (2007) 1.14
Characterization of Staphylococcus aureus enterotoxin L. Infect Immun (2003) 1.13
Multiple functional domains of Enterococcus faecalis aggregation substance Asc10 contribute to endocarditis virulence. Infect Immun (2008) 1.12
The staphylococcal respiratory response regulator SrrAB induces ica gene transcription and polysaccharide intercellular adhesin expression, protecting Staphylococcus aureus from neutrophil killing under anaerobic growth conditions. Mol Microbiol (2007) 1.10
Proinflammatory exoprotein characterization of toxic shock syndrome Staphylococcus aureus. Biochemistry (2011) 1.10
ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand. J Immunol Methods (2008) 1.09
Glycerol monolaurate inhibits Candida and Gardnerella vaginalis in vitro and in vivo but not Lactobacillus. Antimicrob Agents Chemother (2009) 1.09
Glycerol monolaurate inhibits virulence factor production in Bacillus anthracis. Antimicrob Agents Chemother (2005) 1.09
Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. J Pediatr (2002) 1.09
Comparative proteomic profiling of patients with atopic dermatitis based on history of eczema herpeticum infection and Staphylococcus aureus colonization. J Allergy Clin Immunol (2011) 1.08
Cytolysins, superantigens, and pneumonia due to community-associated methicillin-resistant Staphylococcus aureus. J Infect Dis (2009) 1.08
Accelerated gastric emptying but no carbohydrate malabsorption 1 year after gastric bypass surgery (GBP). Obes Surg (2012) 1.07
Bone mineral content is lower in prepubertal HIV-infected children. J Acquir Immune Defic Syndr (2002) 1.06
Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa. J Pharm Sci (2008) 1.06
Immunity to Staphylococcus aureus secreted proteins protects rabbits from serious illnesses. Vaccine (2012) 1.04
Multicomponent methods: evaluation of new and traditional soft tissue mineral models by in vivo neutron activation analysis. Am J Clin Nutr (2002) 1.03
Use of recombinase-based in vivo expression technology to characterize Enterococcus faecalis gene expression during infection identifies in vivo-expressed antisense RNAs and implicates the protease Eep in pathogenesis. Infect Immun (2011) 1.03
Crystal structure of the streptococcal superantigen SpeI and functional role of a novel loop domain in T cell activation by group V superantigens. J Mol Biol (2007) 1.01
Effect of recombinant human growth hormone in the treatment of visceral fat accumulation in HIV infection. J Acquir Immune Defic Syndr (2002) 1.01
The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: cellular mechanisms and clinical implications. Toxicol Pathol (2009) 1.01
Comparison of Staphylococcus aureus strains for ability to cause infective endocarditis and lethal sepsis in rabbits. Front Cell Infect Microbiol (2012) 1.01
Clinical evaluation and management of metabolic and morphologic abnormalities associated with human immunodeficiency virus. Clin Infect Dis (2001) 1.01
Glycerol monolaurate and dodecylglycerol effects on Staphylococcus aureus and toxic shock syndrome toxin-1 in vitro and in vivo. PLoS One (2009) 1.00
Penetration of toxic shock syndrome toxin-1 across porcine vaginal mucosa ex vivo: permeability characteristics, toxin distribution, and tissue damage. Am J Obstet Gynecol (2003) 0.99
In vivo assessment of human vaginal oxygen and carbon dioxide levels during and post menses. J Appl Physiol (1985) (2005) 0.99
Functional analysis of the TCR binding domain of toxic shock syndrome toxin-1 predicts further diversity in MHC class II/superantigen/TCR ternary complexes. J Immunol (2003) 0.98
Total body protein: a new cellular level mass and distribution prediction model. Am J Clin Nutr (2003) 0.98
Liver pathology in morbidly obese patients undergoing Roux-en-Y gastric bypass surgery. Obes Surg (2002) 0.98
Alpha-toxin promotes Staphylococcus aureus mucosal biofilm formation. Front Cell Infect Microbiol (2012) 0.97
The virotoxin model of HIV-1 enteropathy: involvement of GPR15/Bob and galactosylceramide in the cytopathic effects induced by HIV-1 gp120 in the HT-29-D4 intestinal cell line. J Biomed Sci (2003) 0.97
Age-related skeletal muscle decline is similar in HIV-infected and uninfected individuals. J Gerontol A Biol Sci Med Sci (2011) 0.96
Lymphogranuloma venereum in human immunodeficiency virus-infected individuals in New York City. J Clin Gastroenterol (2006) 0.95
Staphylococcal superantigens interact with multiple host receptors to cause serious diseases. Immunol Res (2014) 0.95
Molecular analysis of staphylococcal superantigens. Methods Mol Biol (2014) 0.94
The two-component system Bacillus respiratory response A and B (BrrA-BrrB) is a virulence factor regulator in Bacillus anthracis. Biochemistry (2007) 0.94
Repression of Staphylococcus aureus SrrAB using inducible antisense srrA alters growth and virulence factor transcript levels. Biochemistry (2007) 0.94
Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2004) 0.94
Characterization of two novel pyrogenic toxin superantigens made by an acute rheumatic fever clone of Streptococcus pyogenes associated with multiple disease outbreaks. Infect Immun (2002) 0.94
HIV enteropathy: crypt stem and transit cell hyperproliferation induces villous atrophy in HIV/Microsporidia-infected jejunal mucosa. AIDS (2007) 0.94
Structural, energetic, and functional analysis of a protein-protein interface at distinct stages of affinity maturation. Structure (2003) 0.91
A superantigen hypothesis for the pathogenesis of chronic hyperplastic sinusitis with massive nasal polyposis. Am J Rhinol (2004) 0.91
A single, engineered protein therapeutic agent neutralizes exotoxins from both Staphylococcus aureus and Streptococcus pyogenes. Clin Vaccine Immunol (2010) 0.90
Characterization of a Staphylococcus aureus surface virulence factor that promotes resistance to oxidative killing and infectious endocarditis. Infect Immun (2010) 0.90
Ecto-5'-nucleotidase: a candidate virulence factor in Streptococcus sanguinis experimental endocarditis. PLoS One (2012) 0.90
Novel toxic shock syndrome toxin-1 amino acids required for biological activity. Biochemistry (2008) 0.89
A disintegrin and metalloproteinase 17 (ADAM17) and epidermal growth factor receptor (EGFR) signaling drive the epithelial response to Staphylococcus aureus toxic shock syndrome toxin-1 (TSST-1). J Biol Chem (2012) 0.89
Oxandrolone in the treatment of HIV-associated weight loss in men: a randomized, double-blind, placebo-controlled study. J Acquir Immune Defic Syndr (2006) 0.89
Neutralization of multiple staphylococcal superantigens by a single-chain protein consisting of affinity-matured, variable domain repeats. J Infect Dis (2008) 0.87
Staphylococcus aureus α-toxin modulates skin host response to viral infection. J Allergy Clin Immunol (2012) 0.87
Effects of growth hormone on visceral adipose tissue and dyslipidemia in HIV, an erratum. J Acquir Immune Defic Syndr (2006) 0.86
Formation of vegetations during infective endocarditis excludes binding of bacterial-specific host antibodies to Enterococcus faecalis. J Infect Dis (2002) 0.86
Sequence analysis of the Staphylococcus aureus srrAB loci reveals that truncation of srrA affects growth and virulence factor expression. J Bacteriol (2007) 0.86